Policies for fostering health science, technology and innovation in Brazil and the role of clinical research

被引:6
|
作者
Tenorio, Marge [1 ]
Mello, Guilherme Arantes [2 ]
D'Avila Viana, Ana Luiza [1 ]
机构
[1] Univ Sao Paulo, Fac Med, Dept Med Prevent, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil
[2] Univ Fed Sao Paulo, Escola Paulista Med, Sao Paulo, SP, Brazil
来源
CIENCIA & SAUDE COLETIVA | 2017年 / 22卷 / 05期
关键词
Policies; Healthcare administration and planning; Management of science; Technology and innovation in health; Clinical trials;
D O I
10.1590/1413-81232017225.33342016
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The purpose of this article is to highlight a number of underlying issues that may be useful for a comprehensive review of the management of Health-Related Science, Technology and Innovation policies (ST&I/H), and its strategies and priorities. It is an analytical study supported by an extensive review of the technical and journalistic literature, clippings, legislation and federal government directives. The results show that the Healthcare Production Complex undeniably and increasingly needs science to maintain itself. One may infer that a framework of institutional milestones is being built in Brazil, to strengthen, guide and encourage Research and Development, and that clinical research creates scientific knowledge to address public healthcare issues by generating new inputs or enhancing existing techniques, processes and technologies that will be produced, marketed and used in the different segments, thus feeding the Healthcare Productive Complex.
引用
收藏
页码:1441 / 1454
页数:14
相关论文
共 50 条